Daewoong Co., Ltd. (003090) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Daewoong Co., Ltd. (003090:KRX), powered by AI.

Current Price
₩16,330
P/E Ratio
3.8
Market Cap
949.5B
Sector
Healthcare
What is the Daewoong Co., Ltd. stock price forecast?

Daewoong Co., Ltd. is currently trading at ₩16,330. View real-time AI analysis on Alpha Lenz.

What is Daewoong Co., Ltd. insider trading activity?

View the latest insider trading data for Daewoong Co., Ltd. on Alpha Lenz.

What is Daewoong Co., Ltd.'s P/E ratio?

Daewoong Co., Ltd.'s P/E ratio is 3.8.

Daewoong Co., Ltd.

KRX · 003090
₩16,330-150(-0.91%)Market closedKRX regular session 09:00–15:30 KST
Ask about Daewoong Co., Ltd.'s future dividend policy...
Alpha Chat Insight

Daewoong Co., Ltd. trades at a P/E of 3.8 (undervalued) with strong ROE of 16.1%.

Ask for details

Company Overview

Daewoong Co., Ltd. is a prominent pharmaceutical company primarily engaged in the development, manufacture, and distribution of medicines, medical devices, and healthcare-related products. Founded in South Korea, Daewoong has established itself as a key player in the global pharmaceutical industry. The company's primary focus is on providing innovative and effective healthcare solutions, which encompass a wide range of therapeutic areas including gastrointestinal, anti-diabetic, and cardiovascular treatments. Daewoong is particularly known for its robust research and development initiatives, which aim to address unmet medical needs through cutting-edge technologies and strategic collaborations. The firm plays a significant role in the pharmaceutical supply chain, contributing to the availability of essential medicines and healthcare solutions across both domestic and international markets. Through its commitment to quality and continuous innovation, Daewoong Co., Ltd. remains a vital entity in the advancement of global health and well-being.

CEO윤재춘
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
Employees356

Company Statistics

FY 2025

Profile

₩949,458,533,400Market Cap
₩2,068,370,455,240Revenue
58.14MShares Out
356Employees

Margins

53.34%Gross
16.76%EBITDA
12.66%Operating
11.78%Pre-Tax
11.02%Net

Valuation

3.82P/E
0.57P/B
0.32EV/Sales
5.43EV/EBITDA
-7.39P/FCF

Growth (CAGR)

6.81%Rev 3Yr
8.82%Rev 5Yr
8.08%Op Inc 3Yr
21.70%Op Inc 5Yr
23.75%Net Inc 3Yr
14.00%Net Inc 5Yr

Returns

7.66%ROA
16.11%ROE
8.65%ROIC

Financial Health

₩255,917,494,900Cash & Cash Equivalents
₩1,208,914,076,540Net Debt
82.88%Debt/Equity
N/AInterest Cov

Frequently Asked Questions

Daewoong Co., Ltd. (ticker: 003090) is a company listed on KRX in the Healthcare sector (Drug Manufacturers - Specialty & Generic). It has approximately 356 employees. Market cap is $949.5B.

The current price is ₩16,330 with a P/E ratio of 3.82x and P/B of 0.57x.

ROE is 16.11% and operating margin is 12.66%. Annual revenue is $2.1T.

Alpha Lenz
Singapore
Treasurer Pte Ltd | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2026 Treasurer Pte Ltd. All rights reserved.
Daewoong Co., Ltd. (003090) Stock Forecast 2026 ₩16,330 — Price, Financials & Analyst Targets | Alpha Lenz